Note: Ingredients listed on restricted chemical lists
EC/CAS
423-340-5/162881-26-7
Name of the chemical
Phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide
Concentration
0,1≤x<1
General Information
Revision date
2024-01-15
Product name
Permabond 130UV
Product name
Permabond 130UV
Identification on the label/Trade name
Permabond Engineering Adhesives
1.2.1 Relevant identified uses
Adhesive
supplier name
Permabond Engineering Adhesives Ltd
Emergency telephone
+44 (0)1962 711 661, +(44)-870-8200418, +(353)-19014670, +(61)-290372994, +(64)-98010034
Icons in SDS
Company Information
company name
Permabond Engineering Adhesives Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
info.europe@permabond.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H319, H335
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
The product is classified as hazardous pursuant to the provisions set forth in (EC) Regulation
2.2 Label elements
Hazard labelling pursuant to EC Regulation
Signal word
Warning
Hazard statements
H319 Causes serious eye irritation. H315 Causes skin irritation. H335 May cause respiratory irritation. EUH202 Cyanoacrylate. Danger. Bonds skin and eyes in seconds. Keep out of the reach of children. EUH208
Contains
PHENYL BIS(2,4,6-TRIMETHYLBENZOYL)-PHOSPHINEOXIDE May produce an allergic reaction. ethyl 2-cyanoacrylate
Precautionary statements
P280 Wear protective gloves / protective clothing / eye protection / face protection. P302+P352 In case of contact with the skin: wash abundantly with soap and water. P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
2.3 Other hazards
On the basis of available data, the product does not contain any PBT or vPvB in percentage ≥ than 0,1%. The product does not contain substances with endocrine disrupting properties in concentration ≥ 0.1%.
